Xufei Huang

485 total citations
24 papers, 315 citations indexed

About

Xufei Huang is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Xufei Huang has authored 24 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Neurology and 5 papers in Genetics. Recurrent topics in Xufei Huang's work include Peripheral Neuropathies and Disorders (9 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers) and Autoimmune Bullous Skin Diseases (5 papers). Xufei Huang is often cited by papers focused on Peripheral Neuropathies and Disorders (9 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers) and Autoimmune Bullous Skin Diseases (5 papers). Xufei Huang collaborates with scholars based in China, United Kingdom and United States. Xufei Huang's co-authors include Li J, Daobin Zhou, Xinxin Cao, Chen Wang, Hao Cai, Qianqian Cai, Hao Zhao, Huabing Cai, Chunlan Zhang and Lu Zhang and has published in prestigious journals such as Leukemia, Frontiers in Endocrinology and Retina.

In The Last Decade

Xufei Huang

24 papers receiving 310 citations

Peers

Countries citing papers authored by Xufei Huang

Since Specialization

Citations

This map shows the geographic impact of Xufei Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xufei Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xufei Huang more than expected).

Fields of papers citing papers by Xufei Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xufei Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xufei Huang. The network helps show where Xufei Huang may publish in the future.

Co-authorship network of co-authors of Xufei Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Xufei Huang. A scholar is included among the top collaborators of Xufei Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xufei Huang. Xufei Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Risk-stratified treatment of sonrotoclax with chemotherapy in newly diagnosed acute myeloid leukemia: a study protocol	Future Oncology	Min Wu, Zhen Jin et al.	2
2	Endocrine Evaluation in POEMS Syndrome: A Cohort Study	Frontiers in Endocrinology	Hongbo Yang, Hao Zhao et al.	7
3	What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?	Leukemia	Hao Zhao, Xufei Huang et al.	36
4	Genomic profiling in amyloid light-chain amyloidosis reveals mutation profiles associated with overall survival	Amyloid	Xufei Huang, Jian Sun et al.	11
5	A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome	American Journal of Hematology	Li J, Xufei Huang et al.	49
6	[Curative effects and influenced factors of EMA-CO as an initial regimen for the treatment of high-risk gestational trophoblastic neoplasia].	PubMed	Liu W, Xufei Huang et al.	4
7	At least partial hematological response after first cycle of treatment predicts organ response and long-term survival for patients with AL amyloidosis receiving bortezomib-based treatment	Annals of Hematology	Kaini Shen, Jun Feng et al.	12
8	Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role?	Blood Reviews	Chunlan Zhang, Xufei Huang et al.	18
9	Impact of pretransplant induction therapy on autologous stem cell transplantation for patients with newly diagnosed POEMS syndrome	Leukemia	Li J, Chen Wang et al.	30
10	The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients	Leukemia Research	Xinxin Cao, Wei Su et al.	18
11	Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome	Leukemia	Chen Wang, Xufei Huang et al.	51
12	Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasone	Orphanet Journal of Rare Diseases	Hongbo Yang, Xufei Huang et al.	5
13	Bone lesions in Chinese POEMS syndrome patients: imaging characteristics and clinical implications	PeerJ	Fengdan Wang, Xufei Huang et al.	6
14	Remarkable expression of vascular endothelial growth factor in bone marrow plasma cells of patients with POEMS syndrome	Leukemia Research	Chen Wang, Xufei Huang et al.	31
15	[The usage of Mayo staging system in Chinese patients with primary light chain amyloidosis].	PubMed	Xufei Huang, Jun Feng et al.	2
16	[Autologous peripheral blood hematopoietic stem cell transplantation for patients with primary light chain amyloidosis: experience of 31 cases in a single center].	PubMed	Li J, Jun Feng et al.	1
17	OCULAR MANIFESTATIONS AND TREATMENT OUTCOMES IN CHINESE PATIENTS WITH POEMS SYNDROME	Retina	Xiao Zhang, Qianqian Cai et al.	12
18	[Relationship between tissue inhibitors of metalloproteinase and metastasis and prognosis in breast cancer].	PubMed	Xufei Huang, Li J et al.	4
19	[Ultrasound-guided percutaneous fine-needle puncture cytology in the diagnosis of malignant tumors of the liver].	PubMed	Jianguo Li, Xufei Huang et al.	1
20	[Clinical comparison of four types of IUDs made in China].	PubMed	Haiming Fan, Xufei Huang et al.	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact